Paul Baas, MD, PhD, discusses the benefits of immunotherapy in subpopulations of patients with mesothelioma.
Paul Baas, MD, PhD
Advertisement
Articles by Paul Baas, MD, PhD
Paul Baas, MD, PhD, discusses recent updates in immuno-oncology within the field of mesothelioma.
Dr. Paul Baas from the Netherlands Cancer Institute on the Standard of Care for Mesothelioma Patients
Advertisement
Latest Updated Articles
Dr. Baas on the Standard of Care for Mesothelioma PatientsSeptember 6th 2011
Advertisement
Advertisement
Trending on OncLive
1
FDA Grants Fast Track Designation to Pelareorep in Pretreated SCAC
2
PRAME-Directed Therapies Advance Melanoma Treatment Across Clinical Settings
3
META 10-19 Elicits High Complete Response Rate at Ultra-Low Doses in High-Risk R/R DLBCL
4
Sonrotoclax and Next-Generation BCL-2 Inhibitors for Treating CLL
5